Citodon Forte

Citodon Forte is a prescription analgesic that combines paracetamol and codeine phosphate hemihydrate in a rectal dosage form, marketed in the European Union. It is supplied in standard strengths that provide antipyretic and opioid‑mediated pain relief, and is intended for short‑term use under medical supervision for mild to moderate pain and fever when oral administration is unsuitable. The rectal route provides reliable absorption for patients unable to swallow.

Citodon Forte is indicated for the symptomatic relief of conditions where both pain and fever are present.

- Mild to moderate acute pain such as dental, musculoskeletal, or postoperative discomfort. - Fever associated with viral or bacterial infections when antipyretic therapy is required. - Situations where oral analgesics are contraindicated or not tolerated, utilizing the rectal route. - Short‑term management of pain in patients with dysphagia or nausea. - Adjunctive therapy in multimodal pain regimens under physician guidance. - Use in combination with non‑opioid analgesics when a stronger analgesic effect is required, following clinical assessment.

The safety profile of Citodon Forte reflects the combined actions of paracetamol and codeine, with side effects ranging from mild and transient to rare but serious.

Common: - Nausea or mild stomach upset. - Drowsiness or mild sedation. - Dizziness or light‑headedness. - Constipation or reduced bowel motility. - Headache or mild visual disturbances. - Dry mouth. - Blurred vision. - Mild itching.

Serious: - Respiratory depression, especially with high opioid exposure. - Severe allergic reactions such as rash, itching, swelling, or anaphylaxis. - Hepatotoxicity risk with excessive paracetamol exposure. - Severe hypotension or cardiovascular depression. - Dependence or withdrawal symptoms with prolonged use.

When prescribing Citodon Forte, clinicians should evaluate patient history and consider several precautionary measures to minimize risk.

- Assess liver function before initiating therapy due to paracetamol metabolism. - Evaluate for respiratory conditions such as asthma or COPD, as codeine may depress breathing. - Use caution in patients with a history of substance misuse or dependence. - Avoid use in children under a specified age unless directed by a pediatric specialist. - Consider potential sedation when operating machinery or driving. - Review concomitant medications that may increase bleeding risk. - Monitor for signs of allergic reaction during the first few doses.

Citodon Forte can interact with other medicines, altering its effectiveness or increasing the risk of adverse effects.

Avoid: - Other opioid analgesics or strong central nervous system depressants (e.g., benzodiazepines, barbiturates) – may cause additive respiratory depression. - Monoamine oxidase inhibitors (MAOIs) or serotonergic agents – risk of serotonin syndrome. - Alcohol – enhances sedative effects and respiratory depression. - CYP3A4 inducers (e.g., rifampin, carbamazepine) – may lower codeine effectiveness.

Use with caution: - Anticoagulants (e.g., warfarin) – may increase bleeding tendency. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) – can raise codeine levels. - Hepatotoxic drugs (e.g., isoniazid, certain antitubercular agents) – may exacerbate liver stress. - Anticonvulsants that induce hepatic enzymes – may reduce paracetamol efficacy. - Pregnancy hormones may alter metabolism – monitor closely if used during pregnancy.